Brawn Biotech Limited (BOM:530207)
20.13
-0.42 (-2.04%)
At close: May 25, 2026
Brawn Biotech Market Cap
Brawn Biotech has a market cap or net worth of 60.4 million as of May 27, 2026. Its market cap has decreased by -4.14% in one year.
Market Cap
60.40M
Enterprise Value
58.50M
Revenue
172.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.13
Market Cap Chart
Since August 11, 2005, Brawn Biotech's market cap has increased from 23.22M to 60.40M, an increase of 160.08%. That is a compound annual growth rate of 4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 25, 2026 | 60.40M | -6.42% |
| Dec 31, 2025 | 64.54M | 0.94% |
| Dec 31, 2024 | 63.94M | -2.69% |
| Dec 26, 2023 | 65.71M | 11.17% |
| Dec 30, 2022 | 59.11M | -13.79% |
| Dec 31, 2021 | 68.56M | -6.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 130.01M |
| Shamrock Industrial Company | 121.74M |
| Ortin Global | 111.81M |
| Colinz Laboratories | 110.84M |
| Beryl Drugs | 100.47M |
| Unjha Formulations | 86.61M |
| Ganga Pharmaceuticals | 70.94M |
| Decipher Labs | 70.90M |